In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years

Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, AducanumabПодробнее

WRBL: FDA approves first Alzheimer’s drug in nearly 20 years despite controversyПодробнее

FIGHTING ALZHEIMER'S: US FDA approves first new treatment for disease in nearly 20 yearsПодробнее

FDA approves first Alzheimer’s drug in nearly 20 years despite controversyПодробнее

FDA approves controversial Alzheimer's drugПодробнее

FDA approves first new Alzheimer's disease drug in nearly 20 yearsПодробнее

Celebration & controversy after FDA approves drug to treat early-stage Alzheimer’sПодробнее

Drug Controversy - New Alzheimer's DrugПодробнее

In controversial decision, FDA approves first new Alzheimer's disease drug in nearly 20 yearsПодробнее

FDA approves first new drug for Alzheimer’s disease in nearly 20 yearsПодробнее

In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 yearsПодробнее

FDA Approves First New Alzheimer's Drug in Nearly 20 YearsПодробнее

FDA approves first Alzheimer’s drug in nearly 20 years despite controversyПодробнее

FDA Approves 'Controversial' New Alzheimer's DrugПодробнее

US approves first new Alzheimer's drug in 20 years - BBC NewsПодробнее

FDA Approves Biogen's Aducanumab As First New Alzheimer's Drug In Nearly 20 YearsПодробнее

FDA approves first Alzheimer's drug in nearly 20 yearsПодробнее

LIVE: FDA Approves First New Alzheimer's Drug in Nearly 20 Years | Top NewsПодробнее